Breaking News

Baxter Expands German Cytotoxic Facility

Adds commercial and clinical filling lines

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Baxter International’s BioPharma Solutions business is expanding its facility in Halle, Germany with an additional 1,750 square meters at its cytotoxic fill/finish contract manufacturing facility. The expansion allows the company to support early phase drug formulation through commercial scale-up, product launch and lifecycle management.    The expansion includes the installation of a new commercial filling line with two freeze dryers, as well as a clinical filling line with an additional ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters